Lincoln Pharmaceuticals consolidated net profit declines 12.40% in the March 2022 quarter
Sales rise 28.91% to Rs 102.59 crore
Net profit of Lincoln Pharmaceuticals declined 12.40% to Rs 11.02 crore in the quarter ended March 2022 as against Rs 12.58 crore during the previous quarter ended March 2021. Sales rose 28.91% to Rs 102.59 crore in the quarter ended March 2022 as against Rs 79.58 crore during the previous quarter ended March 2021.For the full year,net profit rose 11.42% to Rs 69.36 crore in the year ended March 2022 as against Rs 62.25 crore during the previous year ended March 2021. Sales rose 11.30% to Rs 472.12 crore in the year ended March 2022 as against Rs 424.19 crore during the previous year ended March 2021.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content